Literature DB >> 2157823

Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly.

R H Perry1, D Irving, G Blessed, A Fairbairn, E K Perry.   

Abstract

A dementing syndrome has been identified in a group of psychiatric cases aged 71-90 years, presenting initially with a subacute/acute confusional state, often fluctuating and associated with visual hallucinations and behavioural disturbances. Clinically, these cases did not meet criteria for a diagnosis of Alzheimer's disease, and many were assigned to the multiinfarct dementia group, although no significant ischaemic lesions were evident at autopsy. Mild extrapyramidal features were apparent in a number of cases but the characteristic clinical triad of Parkinson's disease, i.e., tremor, rigidity, and akinesia, was absent. Detailed neuropathological examination revealed Lewy body formation and selective neuronal loss in brain stem and other subcortical nuclei, accompanied by Lewy body formation in neo- and limbic cortex, at densities well below those previously reported in diffuse Lewy body disease. A variable degree of senile degenerative change was present; numerous senile plaques and minimal neurofibrillary tangles in most cases. Neither the clinical nor the neuropathological features of this group are typical of Parkinson's or Alzheimer's disease, but suggest a distinct neurodegenerative disorder, part of the Lewy body disease spectrum, in which mental symptoms predominate over motor disabilities and lead to eventual psychogeriatric hospital admission. In a sequential series of autopsies conducted on clinically assessed demented patients, neuropathological analysis has indicated that such cases may comprise up to 20% of a hospitalized population of demented old people over the age of 70 years, an observation clearly relevant to the diagnosis and management of dementia in the elderly.

Entities:  

Mesh:

Year:  1990        PMID: 2157823     DOI: 10.1016/0022-510x(90)90236-g

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  67 in total

1.  Did Don Quixote have Lewy body disease?

Authors:  P J García Ruiz; L Gulliksen
Journal:  J R Soc Med       Date:  1999-04       Impact factor: 5.344

2.  Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older.

Authors:  T Rahkonen; U Eloniemi-Sulkava; S Rissanen; A Vatanen; P Viramo; R Sulkava
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-06       Impact factor: 10.154

Review 3.  Neuropsychological characteristics of dementia with Lewy bodies and Parkinson's disease with dementia: differentiation, early detection, and implications for "mild cognitive impairment" and biomarkers.

Authors:  Alexander I Tröster
Journal:  Neuropsychol Rev       Date:  2008-03-06       Impact factor: 7.444

4.  Diagnostic accuracy of Alzheimer's disease: a neuropathological study.

Authors:  O Kosunen; H Soininen; L Paljärvi; O Heinonen; S Talasniemi; P J Riekkinen
Journal:  Acta Neuropathol       Date:  1996       Impact factor: 17.088

5.  Hallucinations and signs of parkinsonism help distinguish patients with dementia and cortical Lewy bodies from patients with Alzheimer's disease at presentation: a clinicopathological study.

Authors:  T A Ala; K H Yang; J H Sung; W H Frey
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-01       Impact factor: 10.154

Review 6.  Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies.

Authors:  Jenny McCleery; Shirlony Morgan; Kevin M Bradley; Anna H Noel-Storr; Olaf Ansorge; Chris Hyde
Journal:  Cochrane Database Syst Rev       Date:  2015-01-30

Review 7.  Antipsychotic medications and the elderly: effects on cognition and implications for use.

Authors:  M J Byerly; M T Weber; D L Brooks; L R Snow; M A Worley; E Lescouflair
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

8.  Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand.

Authors:  Z Walker; D C Costa; R W H Walker; K Shaw; S Gacinovic; T Stevens; G Livingston; P Ince; I G McKeith; C L E Katona
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-08       Impact factor: 10.154

Review 9.  Posterior cortical atrophy: a brief review.

Authors:  Howard S Kirshner; Patrick J M Lavin
Journal:  Curr Neurol Neurosci Rep       Date:  2006-11       Impact factor: 5.081

10.  Neuroleptic sensitivity in patients with senile dementia of Lewy body type.

Authors:  I McKeith; A Fairbairn; R Perry; P Thompson; E Perry
Journal:  BMJ       Date:  1992-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.